Core Viewpoint - KinderCare Learning Companies, Inc. is facing a securities fraud class action lawsuit related to its initial public offering in October 2024, alleging misrepresentations about the child care services offered by the company [3]. Group 1: Lawsuit Details - A class action lawsuit has been filed in the United States District Court for the District of Oregon on behalf of investors who purchased or acquired KinderCare common stock during or traceable to the October 2024 IPO [3]. - The lawsuit alleges violations of the Securities Act of 1933 against KinderCare and certain senior officers, claiming that they made misrepresentations regarding the child care services provided by the company [3]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by October 14, 2025, with the role involving directing the litigation on behalf of other class members [4]. - Participation as a lead plaintiff is not required to share in any potential recovery, and shareholders can remain absent class members if they choose not to take action [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [5].

Core Viewpoint - A securities fraud class action lawsuit has been filed against C3.ai, Inc. for alleged misrepresentations regarding the company's business and the impact of the CEO's health on its operations [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who acquired C3 securities between February 26, 2025, and August 8, 2025 [3]. - Allegations include that the CEO's health significantly affected C3 AI's ability to close deals and that management failed to mitigate this impact, hindering the company's profit and growth potential [4]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by October 21, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [5]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Replimune Group, Inc. (NASDAQ: REPL)?Did you purchase your shares between November 22, 2024, and July 21, 2025, inclusive?Did ...

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of RxSight, Inc. (NASDAQ: RXST)?Did you purchase your shares between November 7, 2024 and July 8, 2025, inclusive?Did you lose money in you ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business and operations between August 8, 2024, and August 14, 2025 [1][2]. Group 1 - The lawsuit represents a class of investors who purchased or acquired Nutex securities during the specified period [1]. - Defendants are accused of providing misleading information that affected the investors' decisions [2]. - The deadline to file papers to serve as lead plaintiff is October 21, 2025, allowing individuals to represent the class in the litigation [3]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has a history of recovering over $3.5 billion for clients and has been recognized for its success in class action litigation [4].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against C3.ai, Inc. for alleged misrepresentations regarding the company's business and the impact of the CEO's health on its operations [1][2]. Group 1: Lawsuit Details - The lawsuit claims that C3.ai's management failed to address the significant impact of the CEO's health on the company's ability to close deals and execute its profit and growth potential [2]. - Investors who purchased C3.ai securities between February 26, 2025, and August 8, 2025, are included in the class [1]. Group 2: Legal Process - Interested parties wishing to serve as lead plaintiff must file papers by October 21, 2025, and representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [3]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [4].

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) between April 29, 2025, and August 5, 2025, inclusive. For more information, submit a form at Snap Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030. A ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Flywire Corporation for alleged misrepresentations regarding the company's revenue growth between February 28, 2024, and February 25, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Flywire securities during the specified period [1]. - The complaint alleges that the defendants made false statements about the strength and sustainability of Flywire's revenue growth [2]. Group 2: Legal Process - Investors wishing to serve as lead plaintiff must file necessary documents by September 23, 2025 [3]. - Participation as a lead plaintiff is not required to share in any potential recovery from the lawsuit [3]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions [4].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Novo Nordisk A/S on behalf of investors who acquired the company's securities between May 7, 2025, and July 28, 2025, alleging misrepresentations regarding the growth potential of its diabetes/obesity drug, GLP-1 [1][3]. Group 1 - The lawsuit claims that the defendants made misrepresentations about Novo's growth potential related to its diabetes/obesity drug, GLP-1 [3]. - The deadline for potential lead plaintiffs to file papers is September 30, 2025 [4]. - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [5].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against KinderCare Learning Companies, Inc. on behalf of investors who purchased shares during the October 2024 IPO, alleging misrepresentations regarding the child care services offered by the company [1][2]. Group 1 - The lawsuit is initiated by a shareholder representing a class of investors who acquired KinderCare's common stock during its initial public offering [1]. - The allegations in the lawsuit focus on misrepresentations made by the defendants concerning the quality of child care provided by KinderCare [2]. - Investors interested in serving as lead plaintiff must file necessary documents by October 14, 2025, and participation does not require serving as lead plaintiff [3]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has a history of recovering over $3.5 billion for clients and has represented both individual investors and large pension funds [4]. - The firm has been recognized for its litigation success, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [4].